INTI
Inhibitor Therapeutics, Inc.
Phase 2
AI-extracted
itraconazole
Basal Cell Carcinoma Nevus Syndrome (BCCNS)
119d ago
Apr 24, 2026
SEC 8-K
verified 2mo ago
Countdown card →